Chikungunya Clinical Trial
Official title:
Post-Chikungunya Rheumatism - Rheumatology Follow-up of Patients After 15 Years
Reunion Island was struck by a severe Chikungunya outbreak in 2005-2006. Three hundred and seven Chikungunya patients were evaluated by 4 rheumatologists 2 months after the initial infection (RHUMATOCHIK study). Eighty-three percents still reported joint pain and 43% joint swelling in telephone interviews after 32 months (Bouquillard et al., 2018). The primary objective of the present study is to assess and classify precisely persistent Chi-related joint diseases after 15 years, in a second rheumatology examination.
Reunion Island was struck in 2005-2006 by the most severe Chikungunya outbreak (seroprevalence 38% (Gérardin et al., 2013)) in a developed but previously non-immunized country, providing an unique opportunity for studying Chikungunya-related joint symptoms and their long-term evolution. In a previous study, the investigators demonstrated that at least 17/73 patients initially classified as Chikungunya-related inflammatory joint diseases after 40 months still suffered from inflammatory joint symptoms fullfilling validated classification criteria after 13 years (Guillot et al., 2020). However, in this monocentric study, the investigators did not consider the full spectrum of Chikungunya-related rheumatic diseases, the population was not fully representative and the sample size was not sufficient to perform statistical analyses nor identify poor prognosis markers. In the RHUMATOCHIK cohort study, 307 patients were evaluated by 4 rheumatologists 2 months after the infection, 83% and 43% reported persistent joint pain and joint swelling respectively after 32 months in potentially biased telephone interviews (Bouquillard et al., 2018). In this context, the present study aims at performing a systematic clinical rheumatologic re-evaluation of the RHUMATOCHIK patients after 15 years, in order to precisely describe and classify the full spectrum of persistent Chikungunya-related joint diseases in a larger population. After a telephone interview and screening questionnaire, these patients will be clinically re-evaluated by a second rheumatologist in a multicenter transversal follow-up study. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT04440774 -
Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.
|
Phase 1 | |
Completed |
NCT05153018 -
Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu
|
N/A | |
Active, not recruiting |
NCT04343521 -
Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases
|
Phase 3 | |
Completed |
NCT03992872 -
Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)
|
Phase 2 | |
Completed |
NCT03382964 -
Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02831699 -
The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico
|
||
Recruiting |
NCT01099852 -
Cohort of Patients Infected by an Arbovirus
|
||
Completed |
NCT06257810 -
Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa
|
Phase 4 | |
Suspended |
NCT05218304 -
Baromètre Santé Adulte 2021-2022
|
N/A | |
Recruiting |
NCT04615364 -
Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia
|
||
Completed |
NCT04650399 -
A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents
|
Phase 3 | |
Not yet recruiting |
NCT04672577 -
Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria
|
||
Completed |
NCT04434846 -
Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia
|
||
Recruiting |
NCT04619823 -
Virological and Immunological Determinants of Arbovirus Infection in New Caledonia
|
N/A | |
Completed |
NCT03101111 -
Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area
|
Phase 2 | |
Completed |
NCT02463968 -
Chikungunya Arthritis in the Americas
|
N/A | |
Active, not recruiting |
NCT04566484 -
Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia
|
Phase 2/Phase 3 | |
Completed |
NCT04603131 -
Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine
|
Phase 1 |